Our News

Cannovum Newsletter

Get the latest information and insights:

Successfully subscribed
Something went wrong while submitting the form.

News and updates

July 4, 2022

Cannovum AG part of the International Expert Hearings on Cannabis Legalization

Cannovum AG has participated in the consultation process of the German government for the legalization of cannabis for Adult-use.

April 27, 2022

Cannovum AG resolves capital increase from authorized capital excluding subscription rights

The Management Board of Cannovum AG today resolved to increase the share capital.

February 9, 2022

Cannovum AG launches Cannabis Medical Education Platform

Cannovum Medical Education (CME) is a free, comprehensive virtual continuing education platform for medical cannabis, in which the medical-therapeutic basics of medical cannabis are scientifically prepared.

January 6, 2022

Cannovum AG now offers Next Day Delivery for medical cannabis

From now on, delivery to every pharmacy throughout Germany will take place directly on the next working day if the order is placed by 12:30 pm.

November 25, 2021

Cannovum AG decides to enter the recreational cannabis market

Following the coalition agreement, Cannovum AG will enter into the recreational cannabis market. The present offer in the field of medical cannabis will be maintained and further expanded.

September 29, 2021

Cannovum AG receives active ingredient license

This is an extension of the wholesale permit and allows the trade of active ingredients. One of the main active ingredients of cannabis is THC, which is considered to have the greatest pharmaceutical potential and therapeutic efficacy.

September 8, 2021

Cannovum AG expands Supervisory Board and Medical Advisory Board

Priv. Doz. Dr. med. habil. Philipp Sewerin is the new member of the supervisory board as well as the Medical Advisory Board. Dr. Sewerin is a specialist in internal medicine and rheumatology at the university clinic in Düsseldorf.

September 6, 2021

Cannovum AG starts European cannabis expansion

Cannovum took the first step and founded Cannovum Iberia LDA, a joint venture between Cannovum and Portuguese entrepreneurs from the cannabis industry.

June 29, 2021

Cannovum AG enters the full-spectrum cannabis extract market

Cannovum has signed a supply agreement for full-spectrum cannabis extracts. The extracts are distributed to pharmacies under Cannovum's own brand. 

June 24, 2021

Cannovum AG enters supply agreement for medical cannabis with Aurora Europe

Cannovum has entered into a long term supply agreement with Aurora Europe. Starting today, Cannovum will distribute the full range of medical cannabis products offered by Aurora to pharmacies throughout Germany.

June 15, 2021

Cannovum AG enters cannabis market segment Dronabinol

Cannovum is pleased to announce a strategic supply partnership for Dronabinol with a European medical cannabis supplier. Products are expected to be sold starting from August as part of the Cannovum brand range.

May 6, 2021

Cannovum AG’s direct listing on the Düsseldorf Stock Exchange

First German medical cannabis company listed on the German stock exchange: shares in Cannovum AG can now be traded on the OTC market of the Düsseldorf Stock Exchange.

April 21, 2021

First German medical cannabis company to provide a sustainable, sun-grown and chemical-pesticide free product line

Our CEO, Pia Marten, spoke with Krautinvest about Cannovum’s unique place on the German market as the first medical cannabis company to employ this sustainable approach to their own product line.

February 12, 2021

Cannovum is now part of the BPC

We are excited to announce our partnership with the BPC, who promote sustainable development of cannabinoid therapies and strengthen the legitimacy of the pharmaceutical cannabinoid industry.

January 5, 2021


Handelsblatt published an entrepreneur profile that covers the motivation of our CEO Pia Marten behind founding Cannovum AG. Find the article here:

December 8, 2020

Market entry Cannovum

With the market entry and the launch of our online shop, Cannovum takes a big step forward to further improve the supply of patients with cannabinoid-based therapies.

November 3, 2020

Cannovum welcomes Sanda Bütow as Head of Medical Affairs.

Sandra has 15 years of experience in the healthcare industry and has led the development of the medical affairs department and the education platform "Aurora Academy" for the Canadian manufacturer Aurora.

October 17, 2020

Meeting in Berlin with Friedrich Merz (Politician/CDU)

Our CEO Pia Marten met Friedrich Merz and other entrepreneurs in Berlin. The discussion focused on topics like digitalization, entrepreneurship, and promotion of innovation.

October 12, 2020

Cannovum received its GMP manufacturing license

This means we can streamline our supply chain by packaging and labeling in Germany.

August 10, 2020

Chief Medical Advisor

We are pleased to announce that Dr. med. Dipl.-Chem. Konrad F. Cimander will support us with his expertise in the field of medical cannabis. Learn more about Dr. Cimander on our Medical Advisory Board:

July 30, 2020

Fully licensed wholesaler

We are now a fully licensed pharmaceutical wholesaler and ready to make our vision come true! Find our licenses here:

July 21, 2020

Moved to Factory Berlin

Cannovum AG has moved to Factory Berlin. We are looking forward to meeting many more innovative companies and expanding our network.

June 24, 2020

Cultivator successfully audited

Cannovum performed a successful GMP audit of its first supplier. We ensure that our cultivators adhere to strict EU GMP regulations, highest standards and quality.

May 22, 2020

Who is the typical German cannabis patient? (English article)

Pia has released an english translation of her well received Krautinvest.de article. Read about her insights from the BfArM survey on Medium:

May 3, 2020

Who is the typical German cannabis patient? (German a

Our CEO and Co-Founder has studied the most comprehensive data on cannabis patients in Germany and shared her insights on Krautinvest.de:

April 24, 2020

Cannovum received the pharmaceutical wholesale license

Cannovum reached another milestone! We were granted the pharmaceutical wholesale license (§52a AMG). See our license below:

March 15, 2020

Cannovum is an official supporting member of the BvCW

We're happy to be part of the network that connects the cannabis industry in Germany and Europe! Learn more about the BvCW on their website:

March 10, 2020

Cannovum is now a member of the VCA

We're proud to announce that we're now an official supporting member of the "VCA", the German association for cannabis dispensing pharmacies.

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.